1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Short-Acting Bronchodilators 1.2.3 Corticosteroids 1.2.4 Methylxanthines 1.2.5 Long-Acting Bronchodilators 1.2.6 Phosphodiesterase-4 Inhibitors 1.2.7 Others 1.3 Market by Application 1.3.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Perspective (2016-2027) 2.2 Chronic Obstructive Pulmonary Disorder (COPD) Growth Trends by Regions 2.2.1 Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Chronic Obstructive Pulmonary Disorder (COPD) Historic Market Share by Regions (2016-2021) 2.2.3 Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Regions (2022-2027) 2.3 Chronic Obstructive Pulmonary Disorder (COPD) Industry Dynamic 2.3.1 Chronic Obstructive Pulmonary Disorder (COPD) Market Trends 2.3.2 Chronic Obstructive Pulmonary Disorder (COPD) Market Drivers 2.3.3 Chronic Obstructive Pulmonary Disorder (COPD) Market Challenges 2.3.4 Chronic Obstructive Pulmonary Disorder (COPD) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Chronic Obstructive Pulmonary Disorder (COPD) Players by Revenue 3.1.1 Global Top Chronic Obstructive Pulmonary Disorder (COPD) Players by Revenue (2016-2021) 3.1.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Players (2016-2021) 3.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Chronic Obstructive Pulmonary Disorder (COPD) Revenue 3.4 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Concentration Ratio 3.4.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disorder (COPD) Revenue in 2020 3.5 Chronic Obstructive Pulmonary Disorder (COPD) Key Players Head office and Area Served 3.6 Key Players Chronic Obstructive Pulmonary Disorder (COPD) Product Solution and Service 3.7 Date of Enter into Chronic Obstructive Pulmonary Disorder (COPD) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Chronic Obstructive Pulmonary Disorder (COPD) Breakdown Data by Type 4.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Historic Market Size by Type (2016-2021) 4.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Type (2022-2027) 5 Chronic Obstructive Pulmonary Disorder (COPD) Breakdown Data by Application 5.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Historic Market Size by Application (2016-2021) 5.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2016-2027) 6.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type 6.2.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) 6.2.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) 6.2.3 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2027) 6.3 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application 6.3.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) 6.3.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) 6.3.3 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2027) 6.4 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country 6.4.1 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021) 6.4.2 North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2016-2027) 7.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type 7.2.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) 7.2.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) 7.2.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2027) 7.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application 7.3.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) 7.3.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) 7.3.3 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2027) 7.4 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country 7.4.1 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021) 7.4.2 Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2016-2027) 8.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type 8.2.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2027) 8.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application 8.3.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2027) 8.4 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region 8.4.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2016-2027) 9.2 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type 9.2.1 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) 9.2.2 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) 9.2.3 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2027) 9.3 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application 9.3.1 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) 9.3.2 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) 9.3.3 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2027) 9.4 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country 9.4.1 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021) 9.4.2 Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size (2016-2027) 10.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type 10.2.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2027) 10.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application 10.3.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2027) 10.4 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country 10.4.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 GSK 11.1.1 GSK Company Details 11.1.2 GSK Business Overview 11.1.3 GSK Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.1.4 GSK Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.1.5 GSK Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.2.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.2.5 Pfizer Recent Development 11.3 Merck 11.3.1 Merck Company Details 11.3.2 Merck Business Overview 11.3.3 Merck Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.3.4 Merck Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.3.5 Merck Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.4.4 Novartis Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.4.5 Novartis Recent Development 11.5 AstraZeneca 11.5.1 AstraZeneca Company Details 11.5.2 AstraZeneca Business Overview 11.5.3 AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.5.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.5.5 AstraZeneca Recent Development 11.6 Boehringer Ingelheim 11.6.1 Boehringer Ingelheim Company Details 11.6.2 Boehringer Ingelheim Business Overview 11.6.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.6.4 Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.6.5 Boehringer Ingelheim Recent Development 11.7 Teva Pharmaceuticals 11.7.1 Teva Pharmaceuticals Company Details 11.7.2 Teva Pharmaceuticals Business Overview 11.7.3 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.7.4 Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.7.5 Teva Pharmaceuticals Recent Development 11.8 Ario Pharma 11.8.1 Ario Pharma Company Details 11.8.2 Ario Pharma Business Overview 11.8.3 Ario Pharma Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.8.4 Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.8.5 Ario Pharma Recent Development 11.9 Roche 11.9.1 Roche Company Details 11.9.2 Roche Business Overview 11.9.3 Roche Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.9.4 Roche Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.9.5 Roche Recent Development 11.10 Ache 11.10.1 Ache Company Details 11.10.2 Ache Business Overview 11.10.3 Ache Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.10.4 Ache Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.10.5 Ache Recent Development 11.11 Almirall 11.11.1 Almirall Company Details 11.11.2 Almirall Business Overview 11.11.3 Almirall Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.11.4 Almirall Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.11.5 Almirall Recent Development 11.12 Aquinox Pharmaceuticals 11.12.1 Aquinox Pharmaceuticals Company Details 11.12.2 Aquinox Pharmaceuticals Business Overview 11.12.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.12.4 Aquinox Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.12.5 Aquinox Pharmaceuticals Recent Development 11.13 Asmacure 11.13.1 Asmacure Company Details 11.13.2 Asmacure Business Overview 11.13.3 Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.13.4 Asmacure Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.13.5 Asmacure Recent Development 11.14 Astellas Pharma 11.14.1 Astellas Pharma Company Details 11.14.2 Astellas Pharma Business Overview 11.14.3 Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Introduction 11.14.4 Astellas Pharma Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) 11.14.5 Astellas Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Short-Acting Bronchodilators Table 3. Key Players of Corticosteroids Table 4. Key Players of Methylxanthines Table 5. Key Players of Long-Acting Bronchodilators Table 6. Key Players of Phosphodiesterase-4 Inhibitors Table 7. Key Players of Others Table 8. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Regions (2016-2021) Table 12. Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Regions (2022-2027) Table 14. Chronic Obstructive Pulmonary Disorder (COPD) Market Trends Table 15. Chronic Obstructive Pulmonary Disorder (COPD) Market Drivers Table 16. Chronic Obstructive Pulmonary Disorder (COPD) Market Challenges Table 17. Chronic Obstructive Pulmonary Disorder (COPD) Market Restraints Table 18. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue by Players (2016-2021) & (US$ Million) Table 19. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Players (2016-2021) Table 20. Global Top Chronic Obstructive Pulmonary Disorder (COPD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disorder (COPD) as of 2020) Table 21. Ranking of Global Top Chronic Obstructive Pulmonary Disorder (COPD) Companies by Revenue (US$ Million) in 2020 Table 22. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disorder (COPD) Revenue (CR5 and HHI) & (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Chronic Obstructive Pulmonary Disorder (COPD) Product Solution and Service Table 25. Date of Enter into Chronic Obstructive Pulmonary Disorder (COPD) Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) (US$ Million) Table 28. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Type (2016-2021) Table 29. Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 30. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 31. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Share by Application (2016-2021) & (US$ Million) Table 32. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Application (2016-2021) Table 33. Global Chronic Obstructive Pulmonary Disorder (COPD) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 34. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 35. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) (US$ Million) Table 36. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) & (US$ Million) Table 37. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) (US$ Million) Table 38. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) & (US$ Million) Table 39. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021) & (US$ Million) Table 40. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027) & (US$ Million) Table 41. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) (US$ Million) Table 42. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) & (US$ Million) Table 43. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) (US$ Million) Table 44. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) & (US$ Million) Table 45. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021) & (US$ Million) Table 46. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027) & (US$ Million) Table 47. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) (US$ Million) Table 48. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) & (US$ Million) Table 49. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) (US$ Million) Table 50. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) & (US$ Million) Table 51. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2016-2021) & (US$ Million) Table 52. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Region (2022-2027) & (US$ Million) Table 53. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) (US$ Million) Table 54. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) & (US$ Million) Table 55. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) (US$ Million) Table 56. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) & (US$ Million) Table 57. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2016-2021) (US$ Million) Table 60. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Type (2022-2027) & (US$ Million) Table 61. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2016-2021) (US$ Million) Table 62. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Application (2022-2027) & (US$ Million) Table 63. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2016-2021) & (US$ Million) Table 64. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size by Country (2022-2027) & (US$ Million) Table 65. GSK Company Details Table 66. GSK Business Overview Table 67. GSK Chronic Obstructive Pulmonary Disorder (COPD) Product Table 68. GSK Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 69. GSK Recent Development Table 70. Pfizer Company Details Table 71. Pfizer Business Overview Table 72. Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Product Table 73. Pfizer Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 74. Pfizer Recent Development Table 75. Merck Company Details Table 76. Merck Business Overview Table 77. Merck Chronic Obstructive Pulmonary Disorder (COPD) Product Table 78. Merck Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 79. Merck Recent Development Table 80. Novartis Company Details Table 81. Novartis Business Overview Table 82. Novartis Chronic Obstructive Pulmonary Disorder (COPD) Product Table 83. Novartis Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 84. Novartis Recent Development Table 85. AstraZeneca Company Details Table 86. AstraZeneca Business Overview Table 87. AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Product Table 88. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 89. AstraZeneca Recent Development Table 90. Boehringer Ingelheim Company Details Table 91. Boehringer Ingelheim Business Overview Table 92. Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Product Table 93. Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 94. Boehringer Ingelheim Recent Development Table 95. Teva Pharmaceuticals Company Details Table 96. Teva Pharmaceuticals Business Overview Table 97. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product Table 98. Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 99. Teva Pharmaceuticals Recent Development Table 100. Ario Pharma Company Details Table 101. Ario Pharma Business Overview Table 102. Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 103. Ario Pharma Recent Development Table 104. Roche Company Details Table 105. Roche Business Overview Table 106. Roche Chronic Obstructive Pulmonary Disorder (COPD) Product Table 107. Roche Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 108. Roche Recent Development Table 109. Ache Company Details Table 110. Ache Business Overview Table 111. Ache Chronic Obstructive Pulmonary Disorder (COPD) Product Table 112. Ache Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 113. Ache Recent Development Table 114. Almirall Company Details Table 115. Almirall Business Overview Table 116. Almirall Chronic Obstructive Pulmonary Disorder (COPD) Product Table 117. Almirall Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 118. Almirall Recent Development Table 119. Aquinox Pharmaceuticals Company Details Table 120. Aquinox Pharmaceuticals Business Overview Table 121. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product Table 122. Aquinox Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 123. Aquinox Pharmaceuticals Recent Development Table 124. Asmacure Company Details Table 125. Asmacure Business Overview Table 126. Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Product Table 127. Asmacure Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 128. Asmacure Recent Development Table 129. Astellas Pharma Company Details Table 130. Astellas Pharma Business Overview Table 131. Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Product Table 132. Astellas Pharma Revenue in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) & (US$ Million) Table 133. Astellas Pharma Recent Development Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type: 2020 VS 2027 Figure 2. Short-Acting Bronchodilators Features Figure 3. Corticosteroids Features Figure 4. Methylxanthines Features Figure 5. Long-Acting Bronchodilators Features Figure 6. Phosphodiesterase-4 Inhibitors Features Figure 7. Others Features Figure 8. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application: 2020 VS 2027 Figure 9. Hospital Case Studies Figure 10. Clinic Case Studies Figure 11. Chronic Obstructive Pulmonary Disorder (COPD) Report Years Considered Figure 12. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Regions: 2020 VS 2027 Figure 15. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Regions (2022-2027) Figure 16. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Players in 2020 Figure 17. Global Top Chronic Obstructive Pulmonary Disorder (COPD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disorder (COPD) as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disorder (COPD) Revenue in 2020 Figure 19. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Type (2016-2021) Figure 20. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share by Type (2022-2027) Figure 21. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2016-2027) Figure 23. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2016-2027) Figure 24. North America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Country (2016-2027) Figure 25. United States Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2016-2027) Figure 29. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2016-2027) Figure 30. Europe Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Country (2016-2027) Figure 31. Germany Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2016-2027) Figure 39. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2016-2027) Figure 40. Asia-Pacific Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Region (2016-2027) Figure 41. China Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2016-2027) Figure 49. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2016-2027) Figure 50. Latin America Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Country (2016-2027) Figure 51. Mexico Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type (2016-2027) Figure 55. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application (2016-2027) Figure 56. Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Country (2016-2027) Figure 57. Turkey Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Chronic Obstructive Pulmonary Disorder (COPD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 61. Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 62. Merck Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 63. Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 64. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 65. Boehringer Ingelheim Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 66. Teva Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 67. Ario Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 68. Roche Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 69. Ache Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 70. Almirall Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 71. Aquinox Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 72. Asmacure Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 73. Astellas Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder (COPD) Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

GSK Pfizer Merck Novartis AstraZeneca Boehringer Ingelheim Teva Pharmaceuticals Ario Pharma Roche Ache Almirall Aquinox Pharmaceuticals Asmacure Astellas Pharma